000 01558nam  2200325zi 4500
0019.933514
003CaOODSP
00520240503153350
006m     o  d f      
007cr |n|||||||||
008240206e202101  onc     ob   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-561/2021E-PDF
24500|aAudit of the controlled substances program at Health Canada : |bfinal report.
264 0|a[Ottawa] : |bHealth Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, |cJanuary 2021.
300 |a1 online resource (30 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Audit du Programme des substances contrôlées de Santé Canada : rapport définitif.
504 |aIncludes bibliographical references.
61010|aCanada. |bHealth Canada|xAuditing.
650 0|aPharmaceutical policy|zCanada|xAuditing.
7101 |aCanada. |bHealth Canada, |eissuing body.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tAudit du Programme des substances contrôlées de Santé Canada : |w(CaOODSP)9.937747
85640|qPDF|s807 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-561-2021-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/internal-audits/controlled-substances-program-2021.html